Mycobacterial RNase E cleaves with a distinct sequence preference and controls the degradation rates of mostMycolicibacterium smegmatismRNAs
Author:
Zhou YingORCID, Sun HuamingORCID, Vargas-Blanco Diego A.ORCID, Martini Maria CarlaORCID, Rapiejko Abigail R., Chase Michael R., Joubran Samantha R., Davis Alexa B., Dainis Joseph P., Kelly Jessica M., Ioerger Thomas R., Roberts Louis A., Fortune Sarah M., Shell Scarlet S.ORCID
Abstract
ABSTRACTThe mechanisms and regulation of RNA degradation in mycobacteria have been subject to increased interest following the identification of interplay between RNA metabolism and drug resistance. Mycobacteria encode multiple ribonucleases that are predicted to participate in mRNA degradation and/or processing of stable RNAs. RNase E is an endoribonuclease hypothesized to play a major role in mRNA degradation due to its essentiality in mycobacteria and its role in mRNA degradation in gram- negative bacteria. Here, we defined the impact of RNase E on mRNA degradation rates transcriptome- wide in the non-pathogenic modelMycolicibacterium smegmatis. RNase E played a rate-limiting role in the degradation of at least 89% of protein-coding genes, with leadered transcripts generally being more affected by RNase E repression than leaderless transcripts. There was an apparent global slowing of transcription in response to knockdown of RNase E, suggesting thatM. smegmatisregulates transcription in responses to changes in mRNA degradation. This compensation was incomplete, as the abundance of most transcripts increased upon RNase E knockdown. We assessed the sequence preferences for cleavage by RNase E transcriptome-wide in bothM. smegmatisandM. tuberculosis, and found a consistent bias for cleavage in C-rich regions. Purified RNase E had a clear preference for cleavage immediately upstream of cytidines, distinct from the sequence preferences of RNase E in gram-negatives. We furthermore report a high-resolution map of mRNA cleavage sites inM. tuberculosis, which occur primarily within the RNase E-preferred sequence context, confirming RNase E as a broad contributor toM. tuberculosistranscriptome structure.
Publisher
Cold Spring Harbor Laboratory
Reference75 articles.
1. WHO. (2021) Global tuberculosis report 2021. World Health Organization, Geneva 2. Njire, M. , Wang, N. , Wang, B. , Tan, Y. , Cai, X. , Liu, Y. , Mugweru, J. , Guo, J. , Hameed, H. M. A. , Tan, S. , Liu, J. , Yew, W. W. , Nuermberger, E. , Lamichhane, G. , Liu, J. , and Zhang, T . (2017) Pyrazinoic Acid Inhibits a Bifunctional Enzyme in Mycobacterium tuberculosis. Antimicrob Agents Chemother 61 3. Loss of RNase J leads to multi-drug tolerance and accumulation of highly structured mRNA fragments in Mycobacterium tuberculosis;PLoS Pathog,2022 4. He, L. , Cui, P. , Shi, W. , Li, Q. , Zhang, W. , Li, M. , and Zhang, Y . (2019) Pyrazinoic Acid Inhibits the Bifunctional Enzyme (Rv2783) in Mycobacterium tuberculosis by Competing with tmRNA. Pathogens 8 5. Clinically prevalent mutations in Mycobacterium tuberculosis alter propionate metabolism and mediate multidrug tolerance;Nat Microbiol,2018
|
|